N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene

C213H298F3N27O7S2 — CID 158046554

About N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene

N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene (PubChem CID 158046554) has the molecular formula C213H298F3N27O7S2 and a molecular weight of 3470.04 g/mol. Its IUPAC name is N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene.

Molecular Properties

• Compound Name: N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene
• PubChem CID: 158046554
• Molecular Formula: C213H298F3N27O7S2
• Molecular Weight: 3470.04 g/mol
• Exact Mass: 3467.32
• IUPAC Name: N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene
• SMILES: C=C(C)C(C)C(=C)C.C=C(C)C(C)C(C)C.C=C(C)C(C)CC.CC1=C(C)CCC=C1.CC1=C(C)CCC=C1.CC1=C(C)CCCC1.CC1C=CCCC1C.CC1CC(C)C(C)C=C1F.CC1CCCCC1C.CCC(C)C(C)C.CCC1=CCCCC1.CCC1=CCCCC1CC.CCC1=CCCCC1CC.CCC1=CCCCC1CC.CCC1CC=CCC1C.CCC1CCCCC1.CS(=O)(=O)Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2c(F)cccc2F)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccn2)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccs2)o1.Nc1nc2ccccc2nc1-c1nnc(Cc2ccccc2)o1
• InChI: InChI=1S/C17H14N6O3S.C17H13N5O.C16H9F2N5O.C15H10N6O.C14H9N5OS.3C10H18.C9H15F.C9H16.C8H16.2C8H14.2C8H12.C8H16.C8H14.C8H16.C8H14.C7H16.C7H14/c1-27(24,25)23-11-7-3-2-6-10(11)16-21-22-17(26-16)14-15(18)20-13-9-5-4-8-12(13)19-14;18-16-15(19-12-8-4-5-9-13(12)20-16)17-22-21-14(23-17)10-11-6-2-1-3-7-11;17-8-4-3-5-9(18)12(8)15-22-23-16(24-15)13-14(19)21-11-7-2-1-6-10(11)20-13;16-13-12(18-9-5-1-2-6-10(9)19-13)15-21-20-14(22-15)11-7-3-4-8-17-11;15-12-11(16-8-4-1-2-5-9(8)17-12)14-19-18-13(20-14)10-6-3-7-21-10;3*1-3-9-7-5-6-8-10(9)4-2;1-6-4-8(3)9(10)5-7(6)2;1-3-9-7-5-4-6-8(9)2;5*1-7-5-3-4-6-8(7)2;2*1-2-8-6-4-3-5-7-8;2*1-6(2)8(5)7(3)4;2*1-5-7(4)6(2)3/h2-9,23H,1H3,(H2,18,20);1-9H,10H2,(H2,18,20);1-7H,(H2,19,21);1-8H,(H2,16,19);1-7H,(H2,15,17);3*7,10H,3-6,8H2,1-2H3;5-8H,4H2,1-3H3;4-5,8-9H,3,6-7H2,1-2H3;7-8H,3-6H2,1-2H3;3-6H2,1-2H3;3,5,7-8H,4,6H2,1-2H3;2*3,5H,4,6H2,1-2H3;8H,2-7H2,1H3;6H,2-5,7H2,1H3;7-8H,1H2,2-5H3;8H,1,3H2,2,4-5H3;6-7H,5H2,1-4H3;7H,2,5H2,1,3-4H3
• InChIKey: FIZFJPCDEIJOTM-UHFFFAOYSA-N
• XLogP: 60.91
• TPSA: 512.66 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 34
• Rotatable Bonds: 30
• Heavy Atoms: 252
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3470.04
LogP ≤ 5	60.91
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene?

The IUPAC name of N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene (CID 158046554) is N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene.

What is the SMILES notation for N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene?

The canonical SMILES for N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene is C=C(C)C(C)C(=C)C.C=C(C)C(C)C(C)C.C=C(C)C(C)CC.CC1=C(C)CCC=C1.CC1=C(C)CCC=C1.CC1=C(C)CCCC1.CC1C=CCCC1C.CC1CC(C)C(C)C=C1F.CC1CCCCC1C.CCC(C)C(C)C.CCC1=CCCCC1.CCC1=CCCCC1CC.CCC1=CCCCC1CC.CCC1=CCCCC1CC.CCC1CC=CCC1C.CCC1CCCCC1.CS(=O)(=O)Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2c(F)cccc2F)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccn2)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccs2)o1.Nc1nc2ccccc2nc1-c1nnc(Cc2ccccc2)o1.

What is the InChIKey of N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene?

The InChIKey is FIZFJPCDEIJOTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H14N6O3S.C17H13N5O.C16H9F2N5O.C15H10N6O.C14H9N5OS.3C10H18.C9H15F.C9H16.C8H16.2C8H14.2C8H12.C8H16.C8H14.C8H16.C8H14.C7H16.C7H14/c1-27(24,25)23-11-7-3-2-6-10(11)16-21-22-17(26-16)14-15(18)20-13-9-5-4-8-12(13)19-14;18-16-15(19-12-8-4-5-9-13(12)20-16)17-22-21-14(23-17)10-11-6-2-1-3-7-11;17-8-4-3-5-9(18)12(8)15-22-23-16(24-15)13-14(19)21-11-7-2-1-6-10(11)20-13;16-13-12(18-9-5-1-2-6-10(9)19-13)15-21-20-14(22-15)11-7-3-4-8-17-11;15-12-11(16-8-4-1-2-5-9(8)17-12)14-19-18-13(20-14)10-6-3-7-21-10;3*1-3-9-7-5-6-8-10(9)4-2;1-6-4-8(3)9(10)5-7(6)2;1-3-9-7-5-4-6-8(9)2;5*1-7-5-3-4-6-8(7)2;2*1-2-8-6-4-3-5-7-8;2*1-6(2)8(5)7(3)4;2*1-5-7(4)6(2)3/h2-9,23H,1H3,(H2,18,20);1-9H,10H2,(H2,18,20);1-7H,(H2,19,21);1-8H,(H2,16,19);1-7H,(H2,15,17);3*7,10H,3-6,8H2,1-2H3;5-8H,4H2,1-3H3;4-5,8-9H,3,6-7H2,1-2H3;7-8H,3-6H2,1-2H3;3-6H2,1-2H3;3,5,7-8H,4,6H2,1-2H3;2*3,5H,4,6H2,1-2H3;8H,2-7H2,1H3;6H,2-5,7H2,1H3;7-8H,1H2,2-5H3;8H,1,3H2,2,4-5H3;6-7H,5H2,1-4H3;7H,2,5H2,1,3-4H3.

What are the key properties of N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene?

N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene has a molecular weight of 3470.04 g/mol, XLogP of 60.91, 30 rotatable bonds, 6 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene is sourced from PubChem (CID 158046554), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).